Publications

Show Filters

Searches all publications.

Search Fulltext

Publications

Section

Select publication to see the relevant sections.

Publication Date

    E.g., 2018-06-21
    E.g., 2018-06-21

Articles

12157 items
8:21 AM, May 29, 2018  |  BC Extra | Financial News

HitGen closes series B round

HitGen Ltd. (Chengdu, China) raised RMB250 million ($39.1 million) in a series B round led by CDH. Also participating were Leadyond Capital and other undisclosed existing investors. HitGen has a DNA-encoded library design, synthesis and screening...
3:48 PM, May 25, 2018  |  BC Extra | Financial News

NEA promotes Chang, Behbahani

New Enterprises Associates promoted Carmen Chang and partner Ali Behbahani to general partner. Chang, a technology investor, is chairman and head of the firm’s Asia practice. Behbahani, who was a partner, is a healthcare investor...
3:08 PM, May 25, 2018  |  BC Extra | Financial News

Eidos, Avrobio propose NASDAQ IPOs

Eidos Therapeutics Inc. (Palo Alto, Calif.) and Avrobio Inc. (Cambridge, Mass.) proposed NASDAQ IPOs on Friday. Eidos proposed to raise $115 million in an IPO underwritten by J.P. Morgan, BofA Merrill Lynch and Barclays. Last month,...
2:08 PM, May 25, 2018  |  BC Extra | Financial News

Immunoproteasome company Kezar files for $80.5M IPO

Kezar Life Sciences (South San Francisco, Calif.) filed Thursday to raise $80.5 million in an IPO on NASDAQ underwritten by Jefferies, Cowen, Wells Fargo and William Blair. Kezar is developing immunoproteasome-targeted therapeutics to selectively suppress the...
10:05 PM, May 24, 2018  |  BC Extra | Financial News

Transplant company Magenta plans $100M listing

Stem cell transplant company Magenta Therapeutics Inc. (Cambridge, Mass.) filed to raise up to $100 million in an IPO on NASDAQ. Underwriters are J.P. Morgan, Goldman Sachs, Cowen and Wedbush PacGrow. Magenta is developing biologics, small...
7:27 PM, May 24, 2018  |  BC Extra | Financial News

Anti-infectives play Iterum raises $80M in IPO

Iterum Therapeutics plc (NASDAQ:ITRM) raised $80 million late Thursday through the sale of 6.2 million shares at $13 in an IPO underwritten by Leerink, RBC Capital Markets, Guggenheim and Needham. The price values Iterum at...
1:03 PM, May 24, 2018  |  BC Extra | Financial News

Celgene authorizes $3B share buyback

Celgene Corp. (NASDAQ:CELG) said its board authorized an expansion of its share buyback program to repurchase up to an additional $3 billion of common stock, on top of the $5 billion buyback it started in...
10:14 AM, May 24, 2018  |  BC Extra | Financial News

Melinta raises $110M in follow-on

Anti-infectives company Melinta Therapeutics Inc. (NASDAQ:MLNT) raised $110 million through the sale of 22 million shares at $5 in a follow-on underwritten by J.P. Morgan, Jefferies and Cantor Fitzgerald. The price is a 32% discount...
5:07 AM, May 24, 2018  |  BC Extra | Financial News

Pivotal closes China fund at $150M

Pivotal bioVenture Partners China closed its USD Fund I at $150 million to invest in Chinese biotechs with in-licensed portfolios. Pivotal China's Jimmy Wei told BioCentury the VC plans to raise another $50 million toward...
9:18 PM, May 23, 2018  |  BC Extra | Financial News

Scholar Rock shares rise after IPO

Scholar Rock Holding Corp. (NASDAQ:SRRK) gained $1.50 (11%) to $15.50 in its first day of trading Thursday after raising $75 million through the sale of 5.4 million shares at $14 in an IPO. Jefferies, Cowen,...

Pages